<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02959580</url>
  </required_header>
  <id_info>
    <org_study_id>PUMCH-breast-mastitis</org_study_id>
    <nct_id>NCT02959580</nct_id>
  </id_info>
  <brief_title>Medical and Surgical Treatment for Idiopathic Granulomatous Mastitis</brief_title>
  <acronym>MSTIGM</acronym>
  <official_title>Evaluation of Topical Steroids and Surgical Treatment for Idiopathic Granulomatous Mastitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the clinical response rate of topical steroids in the treatment of
      idiopathic granulomatous mastitis in female adults. Half of the participants will receive
      topical steroid and the other half will receive local wide surgical excision.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Idiopathic granulomatous mastitis (IGM) is a rare benign inflammatory breast disease of
      unknown etiology.It may present with many findings that clinically and radiologically mimic
      breast cancer.

      Although IGM as a disease has been known for nearly four decades, the optimal treatment
      approach has not been established. Surgical intervention in the form of wide surgical
      excision was the mainstay of treatment before 1980, and is still performed depending on local
      expertise and preference.

      Currently,surgical treatment and systemic steroid treatment are frequently employed. With the
      consideration of side effects of longterm systemic (oral) steroid usage, topical steroid
      without systemic use were assessed and showed satisfactory curative effect. But the data
      concerning the use of topical steroid therapy are still very limited.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>clinical response rate</measure>
    <time_frame>six months</time_frame>
    <description>The clinical response is categorized into ''completely healed,'' ''inadequately healed,'' ''stable,'' ''worsened,'' or ''relapsed'' if the lesions had once healed but symptoms returned.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>granulomatous mastitis recurrence</measure>
    <time_frame>two years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Granulomatous Mastitis</condition>
  <arm_group>
    <arm_group_label>medical</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hydrocortisone butyrate cream(0.1%) was applied to the breast by the patient twice a day on alternate days until the termination of treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>surgical</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>lesion extended excision</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrocortisone Butyrate</intervention_name>
    <description>topical use</description>
    <arm_group_label>medical</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>extended excision</intervention_name>
    <description>Lesion extended excision with or without a random breast dermo-glandular flap (BDGF).</description>
    <arm_group_label>surgical</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Idiopathic Granulomatous Mastitis

        Exclusion Criteria:

          -  Breast Carcinoma
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qiang Sun, master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking Union Medical College Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yanna Zhang, M.D.</last_name>
    <phone>86-10-69152701</phone>
    <email>pumchzyn@sohu.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Breast Surgery,Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qiang Sun, Master</last_name>
      <phone>86-010-69152700</phone>
      <email>sunqiangpumc@sina.com</email>
    </contact>
    <contact_backup>
      <last_name>Yanna Zhang, Doctor</last_name>
      <phone>86-010-69152701</phone>
      <email>pumchzyn@sohu.com</email>
    </contact_backup>
    <investigator>
      <last_name>Qiang Sun, Master</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Altintoprak F, Kivilcim T, Yalkin O, Uzunoglu Y, Kahyaoglu Z, Dilek ON. Topical Steroids Are Effective in the Treatment of Idiopathic Granulomatous Mastitis. World J Surg. 2015 Nov;39(11):2718-23. doi: 10.1007/s00268-015-3147-9.</citation>
    <PMID>26148520</PMID>
  </reference>
  <reference>
    <citation>Sheybani F, Naderi HR, Gharib M, Sarvghad M, Mirfeizi Z. Idiopathic granulomatous mastitis: Long-discussed but yet-to-be-known. Autoimmunity. 2016 Jun;49(4):236-9. doi: 10.3109/08916934.2016.1138221. Epub 2016 Feb 1. Review.</citation>
    <PMID>26829298</PMID>
  </reference>
  <reference>
    <citation>Benson JR, Dumitru D. Idiopathic granulomatous mastitis: presentation, investigation and management. Future Oncol. 2016 Jun;12(11):1381-94. doi: 10.2217/fon-2015-0038. Epub 2016 Apr 12. Review.</citation>
    <PMID>27067146</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2016</study_first_submitted>
  <study_first_submitted_qc>November 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2016</study_first_posted>
  <last_update_submitted>January 18, 2017</last_update_submitted>
  <last_update_submitted_qc>January 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Granulomatous</keyword>
  <keyword>Mastitis</keyword>
  <keyword>topical steroids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mastitis</mesh_term>
    <mesh_term>Granulomatous Mastitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
    <mesh_term>Hydrocortisone acetate</mesh_term>
    <mesh_term>Cortisol succinate</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
    <mesh_term>Butyric Acid</mesh_term>
    <mesh_term>Hydrocortisone-17-butyrate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

